191 related articles for article (PubMed ID: 6365873)
1. Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin.
Marier RL; McCloskey RV; Dickenson G; Sanders CV; Aldridge KE; Hoffman T; Gutterman D; Janney A
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():133-9. PubMed ID: 6365873
[TBL] [Abstract][Full Text] [Related]
2. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
Keller CA; Villavicencio J; Ramirez C
Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
[TBL] [Abstract][Full Text] [Related]
4. Imipenem/cilastatin for pediatric infections in hospitalized patients.
Nalin DR; Hart CB; Shih WJ; Aziz MA
Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
[TBL] [Abstract][Full Text] [Related]
5. Imipenem/cilastatin therapy for serious infections in neonates and infants.
Nalin DR; Jacobsen CA
Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
Wang C; Pappas F; Cook T
Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
[TBL] [Abstract][Full Text] [Related]
7. Role of imipenem/cilastatin in the treatment of soft tissue infections.
Marier RL
Am J Med; 1985 Jun; 78(6A):140-4. PubMed ID: 3890534
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
Unertl K; Lenhart FP; Ruckdeschel G
Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery].
Mayer M; Brand J; Schlenkhoff D; Opferkuch W
Infection; 1986; 14 Suppl 2():S160-3. PubMed ID: 3079549
[TBL] [Abstract][Full Text] [Related]
10. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Colardyn F; Faulkner KL
J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
[TBL] [Abstract][Full Text] [Related]
11. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
Reutter FW
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
[TBL] [Abstract][Full Text] [Related]
13. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
Calandra GB; Hesney M; Brown KR
Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
[TBL] [Abstract][Full Text] [Related]
14. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
Lode H; Wiley R; Höffken G; Wagner J; Borner K
Antimicrob Agents Chemother; 1987 Oct; 31(10):1491-6. PubMed ID: 3324956
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
Unertl K; Ruckdeschel G; Forst H; Lenhart FP
Infection; 1986; 14 Suppl 2():S176-80. PubMed ID: 3759253
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
[TBL] [Abstract][Full Text] [Related]
18. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
Brooks RG; McCabe RE; Vosti KL; Remington JS
Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
[TBL] [Abstract][Full Text] [Related]
19. A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin.
Ribner BS; Raeder R; Hollstein M; Freimer EH
J Antimicrob Chemother; 1983 Oct; 12(4):387-91. PubMed ID: 6358177
[TBL] [Abstract][Full Text] [Related]
20. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
Pastel DA
Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
